Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biodesix Inc
(NQ:
BDSX
)
1.810
+0.050 (+2.84%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Biodesix Inc
< Previous
1
2
3
4
Next >
Biodesix to Present at the 42nd Annual William Blair Growth Stock Conference
June 01, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present at the H.C. Wainwright Global Investment Conference
May 17, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to be Presented at ATS 2022 International Conference
May 12, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces First Quarter 2022 Results and Highlights
May 11, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Report First Quarter 2022 Financial Results on May 11, 2022
April 27, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix Strengthens Financial Position with Equity Issuance and Amendment to Term Loan
April 11, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Publication Further Validating the Use of Liquid Biopsies and NGS Techniques to Provide Clinical Information for Patients With Cancer
March 29, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Fourth Quarter and Year End 2021 Results and Highlights
March 14, 2022
From
Biodesix
Via
Business Wire
Biodesix to Report Fourth Quarter and Full Year 2021 Financial Results on March 14, 2022
February 28, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix CEO Scott Hutton Named to The Healthcare Technology Report’s List of Top 25 Biotech CEOs in 2022
February 22, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue (Unaudited)
February 14, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 09, 2022
From
Biodesix, Inc.
Via
Business Wire
PierianDx and Biodesix Partner to Advance Lung Cancer Diagnostics
January 19, 2022
From
PierianDx
Via
Business Wire
Biodesix Announces the Launch of its GeneStrat NGS™ Test and the IQLung™ Testing Strategy with Unprecedented Time to Results
January 18, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix Strengthens Financial Position with Equity Issuance and Amendment to Term Loan
January 04, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Appointment of Successful Innovator and Scientific Professional Jon Faiz Kayyem, PhD to Board of Directors
December 08, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Publication Highlighting Interim Data from the INSIGHT Study Assessing the Clinical Effectiveness of VeriStrat® Proteomic Test in the Journal of Immunotherapy of Cancer
November 18, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix Partners with Spesana to Streamline Digital Access to Molecular Diagnostics for Precision Medicine in Lung Cancer
December 01, 2021
From
Biodesix
Via
Business Wire
Biodesix Announces Third Quarter 2021 Results and Highlights
November 15, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present Data Supporting Proteomic-Based Immunotherapy Diagnostic Tests and AI Explainability in Diagnostic Tests at Society for Immunotherapy of Cancer Annual Meeting
November 12, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
November 11, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Report Third Quarter 2021 Financial Results on November 15, 2021
November 01, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces New Data on Nodify Lung® Nodule Risk Assessment Testing at the CHEST 2021 Annual Meeting
October 13, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Abstracts Presented During the IASLC 2021 World Conference on Lung Cancer
September 16, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference
September 02, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix DeSoto Laboratory Receives both ISO 13485:2016 Certification and Accreditation from the College of American Pathologists
August 25, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Second Quarter 2021 Results and Highlights
August 10, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present at the Canaccord Genuity 41st Annual Growth Conference
August 02, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Report Second Quarter 2021 Financial Results on August 10, 2021
July 27, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Presentation on Novel Proteomic Techniques in Partnership with Seer
June 17, 2021
From
Biodesix, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.